NCT06193772

Brief Summary

The overarching research project aims to evaluate of an internet-delivered affect-focused psychodynamic treatment (IPDT) for adolescents aged 15-19 with depression. The previous study was a non-inferiority randomized controlled trial (RCT) comparing IPDT with internet-delivered cognitive behavior therapy (ICBT). The results showed that IPDT and ICBT had similar effects. Adolescents in both treatments showed large improvements in both depression and other outcome measures. Online psychological treatment is also known as guided self-help, where the participant reads texts and performs exercises on their own, with the support of an online therapist. The planned study is an RCT to investigate the effect of therapist feedback and customized treatment for adolescents at risk of not being helped by IPDT. The study builds on analyses of predicted treatment trajectories in the project's previous study. Based on these analyses, algorithms have been developed that identify which young people who, after three weeks of treatment, are at risk of not getting a good outcome from the treatment. In the present study, 240 young people aged 15-19 with major depression will begin IPDT. After three weeks of treatment, the course of the treatment is analyzed using the algorithm and the young people who are at risk of not having a good outcome are identified. These adolescents are randomized to either continue unchanged treatment or to receive detailed therapist feedback on the adolescent's treatment prognosis and instructions to adapt the treatment in consultation with the individual adolescent. The IPDT treatment consists of eight modules and treatment duration is ten weeks. The study evaluates the effect of the treatment on depression and other variables such as anxiety symptoms, emotion regulation and self-image. The project's previous studies have shown that IPDT is an effective treatment that can be offered to adolescents with depression. The planned study can show whether the outcome of IPDT can be further improved by paying attention to adolescents with poorer treatment progress and adapting the treatment more to their needs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 11, 2023

Completed
25 days until next milestone

First Posted

Study publicly available on registry

January 5, 2024

Completed
21 days until next milestone

Study Start

First participant enrolled

January 26, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

May 21, 2025

Status Verified

May 1, 2025

Enrollment Period

11 months

First QC Date

December 11, 2023

Last Update Submit

May 16, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Response to treatment according to the proportion improvement method

    treatment response is defined as over 50% improvement within the pathological range and at least 25% improvement within the total range on the Quick Inventory of Depressive Symptomatology in Adolescents Self-Rated (QIDS-A17-SR)

    Pre-treatment and after 10 weeks (end of treatment)

Secondary Outcomes (5)

  • Severity of depressive symptoms

    Pre-treatment, weekly during treatment, after 10 weeks (end of treatment) and one-year follow-up

  • Anxiety symptoms

    Pre-treatment, post-treatment, one-year follow-up

  • Difficulties in emotion regulation

    Pre-treatment and after 10 weeks (end of treatment)

  • Self-concept and identity

    Pre-treatment, after 10 weeks (end of treatment), one-year follow-up

  • Defence mechanism functioning

    Pre-treatment and after 10 weeks (end of treatment)

Study Arms (3)

IPDT as usual for "on track" patients

ACTIVE COMPARATOR

IPDT as usual for patients who are identified as "on track" at week 3.

Behavioral: Internet-delivered psychodynamic therapy (IPDT)

IPDT adapted for "at risk" patients

EXPERIMENTAL

Customized IPDT after therapist feedback for patients who are identified as "at risk" at week 3.

Behavioral: Internet-delivered psychodynamic therapy (IPDT)

IPDT as usual for "at risk" patients

ACTIVE COMPARATOR

IPDT as usual for patients who are identified as "at risk" at week 3.

Behavioral: Internet-delivered psychodynamic therapy (IPDT)

Interventions

IPDT consists of 8 therapist-supported self-help modules delivered over 10 weeks on a secure online platform. Modules consist of texts and video followed by assignments which they send to their therapist and receive feedback within a few days. The intervention "IPDT adapted" starts with therapist feedback about the patient's predicted progress and continues with adapting the treatment to the individual adolescent, for example adding text chat sessions.

IPDT adapted for "at risk" patientsIPDT as usual for "at risk" patientsIPDT as usual for "on track" patients

Eligibility Criteria

Age15 Years - 19 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsSelf-reported gender identity with alternatives 1) female, 2) male, 3) other alternative, 4) uncertain, 5) do not want to answer
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Adolescents 15-19 years of age suffering from mild to moderate major depressive disorder (MDD) according to DSM-5 as established through a diagnostic interview (MINI 7.0 Sheehan et al., 1998). MDD should be the primary diagnosis. Participants must have access to a computer/smart phone/tablet with internet connection, and be able to read, write and speak Swedish without the aid of an interpreter.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Psychology, Stockholm University

Stockholm, 10691, Sweden

Location

Study Officials

  • Björn Philips, Ph.D.

    Stockholm University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: All eligible participants (n = 240) will be entered into IPDT. At week 3 in treatment, participants at risk of non-response will be identified using our open-source algorithm. Identified participants at risk will be randomized to either adapted treatment or continued IPDT as usual.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 11, 2023

First Posted

January 5, 2024

Study Start

January 26, 2024

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

May 21, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

IPD that underlie results in a publication will be shared to other researchers after reasonable request.

Shared Documents
STUDY PROTOCOL
Time Frame
Study protocol will be published before the end of enrollment.
Access Criteria
IPD will be shared to other researchers for IPD meta-analyses after reasonable request. The principal investigator will review requests.

Locations